T2 Biosystems Shares Plummet 47% on 3Q Revenue Outlook

By Denny Jacob T2 Biosystems shares plummeted 47% to $9.19 on forecasts of lower revenue in the third-quarter. The stock is down 93% on the year so far....

Related Keywords

John Sperzel ,Denny Jacob ,Development Authority ,Biomedical Advanced Research ,Executive John Sperzel ,Article Normal ,Medical Equipment Supplies ,Healthcare Life Sciences ,Medical Diagnostic Equipment Supplies ,Medical Devices Apparatus ,Diagnostic Therapeutic Devices ,Financial Performance ,Share Price Movement Disruptions ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,T2 Biosystems ,Tattoo ,Us89853l3024 ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Medical Equipment ,Supplies ,Healthcare ,Life Sciences ,Medical Diagnostic Equipment ,Medical Devices ,Apparatus ,Diagnostic ,Therapeutic Devices ,